These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 7374998)
61. [Coenzyme A in chronic hepatopathies]. Colorizio V; Farina E; Festuccia V; Casale R Clin Ter; 1979 Dec; 91(6):607-15. PubMed ID: 544163 [No Abstract] [Full Text] [Related]
62. [Treatment of chronic hepatopathies with phosphorylcholine and pantethine]. Proietti C; Imperiale A; Chiti D Clin Ter; 1984 Aug; 110(3):251-7. PubMed ID: 6237863 [No Abstract] [Full Text] [Related]
63. [Behaviour of ammonemia during treatment of chronic/hyperammonemic hepatopathy with S-adenosyl-L-methionine]. De Caprio M; Carbone G; Cerotto GM; Corbosiero L; Vitale A Clin Ter; 1980 Mar; 92(6):587-602. PubMed ID: 7460488 [No Abstract] [Full Text] [Related]
64. Branched-chain amino acid-enriched supplementation improves insulin resistance in patients with chronic liver disease. Kawaguchi T; Nagao Y; Matsuoka H; Ide T; Sata M Int J Mol Med; 2008 Jul; 22(1):105-12. PubMed ID: 18575782 [TBL] [Abstract][Full Text] [Related]
65. [The efficacy of pharmacotherapy in patients with chronic liver pathology and the function of the antioxidant defense enzymes]. Loginov AS; Matiushin BN; Iakimchuk GN Ter Arkh; 1995; 67(2):3-6. PubMed ID: 7725254 [No Abstract] [Full Text] [Related]
66. [Tissue distribution of carbon-14 following oral administration of 14C-arginine thiazolidinecarboxylate in rats]. Nebuloni R; Falchi M; Dubini F Farmaco Prat; 1981 Jul; 36(7):333-5. PubMed ID: 7274414 [No Abstract] [Full Text] [Related]
67. [Drug therapy of liver diseases]. Kautzsch E Med Monatsschr; 1971 Jan; 25(1):15-7. PubMed ID: 5546750 [No Abstract] [Full Text] [Related]
68. [Liver damage due to chlorpromazine and its treatment with arginine glucose-1-phosphate]. Poggi E; Ferrari G Epatologia; 1971; 17(1):127-31. PubMed ID: 5147857 [No Abstract] [Full Text] [Related]
69. A preliminary study on the activation of superoxide dismutase by Tiopronin in patients with chronic hepatitis B. Chen C; Tan Z; Qiu S Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Dec; 14(4):355-7. PubMed ID: 11471025 [TBL] [Abstract][Full Text] [Related]
70. [The clinical significance of the enzymatic system utilizing active forms of oxygen in chronic liver diseases]. Loginov AS; Matiushin BN Ter Arkh; 1994; 66(4):65-8. PubMed ID: 8016735 [TBL] [Abstract][Full Text] [Related]
71. [Bile acids in the therapy of chronic liver diseases]. Sperandeo M; Varriale A; Sperandeo G; Carughi S; Lucentini L Recenti Prog Med; 1993 Mar; 84(3):225-30. PubMed ID: 8465104 [TBL] [Abstract][Full Text] [Related]
72. Etiologies of chronic liver diseases in Hong Kong. Fung KT; Fung J; Lai CL; Yuen MF Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):659-64. PubMed ID: 17625435 [TBL] [Abstract][Full Text] [Related]
73. [Diagnostic value of serum bile acids in chronic diseases of the liver]. Testa R; Bocchini R; Dellepiane F; Dodero M; Celle G Med Chir Dig; 1980; 9(2):95-7. PubMed ID: 7401731 [No Abstract] [Full Text] [Related]
78. Movement disorders as a manifestation of metronidazole-induced encephalopathy in a patient with chronic liver disease. Galvez M; Brahm J; Miranda M Mov Disord; 2009 Sep; 24(12):1864-6. PubMed ID: 19452566 [No Abstract] [Full Text] [Related]
79. [Bile acids in therapy of liver diseases]. Leuschner U Internist (Berl); 1994 Dec; 35(12):1147-55. PubMed ID: 7883518 [No Abstract] [Full Text] [Related]
80. [Effect of chloroquine treatment of porphyria cutanea tarda on the associated liver disease]. Wolff Fernández C; Krause Ianpaglia P; Franco Silva C; Armas Merino R Rev Invest Clin; 2000; 52(2):211-3. PubMed ID: 10846447 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]